Clover Health Investments
CLOV
175 hedge funds and large institutions have $234M invested in Clover Health Investments in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 25 closing their positions.
60% more call options, than puts
Call options by funds: $7.99M | Put options by funds: $4.98M
43% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 40
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 25
0.11% less ownership
Funds ownership: 32.28% → 32.17% (-0.11%)
1% less funds holding
Funds holding: 176 → 175 (-1)
11% less capital invested
Capital invested by funds: $262M → $234M (-$28.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$6.16M |
| 2 |
BlackRock
New York
|
+$3.8M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.29M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$1.24M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
-$5.66M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.1M |
| 3 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
-$2.12M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.85M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.76M |
CLOV Hedge Fund Activity: Q3 2022 in Review
175 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q3 2022, worth a combined $234M — down 11% from $262M a quarter earlier.
Fund positioning in CLOV was balanced in Q3 2022: 25 funds opened new positions, 25 closed out, 57 added to existing stakes and 40 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $6.16M. The largest seller was Two Sigma Advisers, cutting an estimated $5.66M.
- 175 institutional investors held Clover Health Investments (CLOV) as of Q3 2022, down from 176 in Q2 2022.
- Funds reported $234M of Clover Health Investments stock for Q3 2022, down 11% quarter-over-quarter.
- 25 funds opened new Clover Health Investments positions in Q3 2022 and 25 closed out, a net change of 0 holders.
- The largest Clover Health Investments buyer in Q3 2022 was Renaissance Technologies, an estimated $6.16M added.
- The largest Clover Health Investments seller in Q3 2022 was Two Sigma Advisers, an estimated $5.66M sold.
Based on aggregated 13F filings for Q3 2022.